GALENIX DEV has a total of 16 patent applications. Its first patent ever was published in 1993. It filed its patents most often in France, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals are QINGDAO CHANG'ANDA PHARMACEUTICAL IND CO LTD, LI HOUJIAN and BOZHOU QINGJU PHARMACEUTICAL SALE CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | France | 3 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Israel | 2 | |
#5 | United States | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Australia | 1 | |
#8 | Brazil | 1 | |
#9 | Hungary | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Besse Jerome | 12 |
#2 | Roux Jacques | 1 |
#3 | Saboureau Dominique | 1 |
Publication | Filing date | Title |
---|---|---|
EP1935412A2 | Pharmaceutical composition containing 5-chloro-1-[1-[3-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)propyl]piperidine-4-yl]-1,3-dihydro-2H-benzimidazol-2-one and method of preparing same | |
FR2797185A1 | Floating pharmaceutical composition comprising an active and a non-active phase | |
FR2766708A1 | Composition containing hydroxypropylcellulose, hydroxypropylmethylcellulose and / or ethylcellullose as disintegrants, and process for obtaining same | |
FR2766707A1 | Medicaments containing cellulose based disintegration agents | |
WO9418962A1 | Pharmaceutical compositions for transdermal fenfluramine delivery |